Search results
Found 581 matches for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Project Administrator (180358)
An exciting opportunity to assist the Clinical Trial Managers of the Oxford Trauma and Emergency Care group in the successful delivery of research projects.
Clinical Research Fellow (179828)
Join our interdisciplinary team and develop your clinical experience and expertise in the management of adults with rare bone disorders.
Meet Chris
-
Christopher Buckley
Kennedy Professor of Translational Rheumatology and Director of Clinical Research
